1-5 of 5
Yves Allory
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A113: National multidisciplinary tumor board improves diagnostic stratification and therapeutic management in cancers of unknown primary

Ivan Bieche, Maud Kamal, Nicolas Jacquin, Célia Dupain, Isabelle Guillou, Etienne Rouleau, Julien Masliah Planchon, Isabelle Soubeyran, Christelle De La Fouchardière, Camille Tlemsani, Hélène Blons, Laëtitia Marisa, Anna Patrikidou, Fabienne Escande, Pierre Blanc, Jennifer Wong, Pierre Saintigny, Sandrine Boyault, Adrien Buisson, Yves Allory, Anne Vincent-Salomon, Vincent Cockenpot, Janick Selves, Christophe Le Tourneau, Sarah Watson
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (12_Supplement): A113.
https://doi.org/10.1158/1535-7163.TARG-23-A113
Published: 01 December 2023
View article titled, Abstract A113: National multidisciplinary tumor board improves diagnostic stratification and therapeutic management in cancers of unknown primary
Journal Articles

Abstract B005: Impact of molecular profiling and ESCAT classification on patient outcome: The experience of Institut Curie Molecular Tumor Board

Maud Kamal, Kimya Rahmani Narj Abadi, Raphaël Sanchez, Célia Dupain, Isabelle Guillou, Grégoire Marret, Zahra Castel Ajgal, Marie Paule Sablin, Cindy Neuzillet, Amani Asnacios Lecerf, Edith Borcoman, Ségolène Hescot, Florence Coussy, Manuel Rodrigues, Nicolas Girard, Sarah Watson, Julien Masliah Planchon, Jennifer Wong, Abderaouf Hamza, Celine Callens, Olfa Trabelsi Grati, Samia Melaabi, Keltouma Driouch, Emmanuelle Mouret-Fourme, Chrystelle Colas, Samantha Antonio, Odette Mariani, Michèle Nijnikoff, Anne Vincent-Salomon, Yves Allory, Ivan Bieche, Christophe Le Tourneau
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (12_Supplement): B005.
https://doi.org/10.1158/1535-7163.TARG-23-B005
Published: 01 December 2023
View article titled, Abstract B005: Impact of molecular profiling and ESCAT classification on patient outcome: The experience of Institut Curie Molecular Tumor Board
Journal Articles

Abrogation of De novo Lipogenesis by Stearoyl-CoA Desaturase 1 Inhibition Interferes with Oncogenic Signaling and Blocks Prostate Cancer Progression in Mice

Vanessa Fritz, Zohra Benfodda, Geneviève Rodier, Corinne Henriquet, François Iborra, Christophe Avancès, Yves Allory, Alexandre de la Taille, Stéphane Culine, Hubert Blancou, Jean Paul Cristol, Françoise Michel, Claude Sardet, Lluis Fajas
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (6): 1740–1754.
https://doi.org/10.1158/1535-7163.MCT-09-1064
Published: 09 June 2010
View article titled, Abrogation of <em>De novo</em> Lipogenesis by Stearoyl-CoA Desaturase 1 Inhibition Interferes with Oncogenic Signaling and Blocks Prostate Cancer Progression in Mice
Open the PDF for Abrogation of <em>De novo</em> Lipogenesis by Stearoyl-CoA Desaturase 1 Inhibition Interferes with Oncogenic Signaling and Blocks Prostate Cancer Progression in Mice in another window
Includes: Supplementary data
Journal Articles

Abstract B92: P38 MAPK activation is critical for FGFR3‐induced cell transformation in human bladder carcinoma

Isabelle Bernard‐Pierrot, Claire Dunois‐Larde, Nicolas Stransky, Aurelie Herault, May‐Linda Lepage, Slah Ouerhani, Claude Abbou, Agnes Laplanche, Simone Benhamou, Thierry Lebret, Yves Allory, François Radvanyi
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): B92.
https://doi.org/10.1158/1535-7163.TARG-09-B92
Published: 10 December 2009
View article titled, Abstract B92: P38 MAPK activation is critical for FGFR3‐induced cell transformation in human bladder carcinoma
Journal Articles

Abstract B175: Lactadherin/MFGE8 favors bladder tumor progression by promoting tolerogenic immune responses

Isabelle Bernard‐Pierrot, Gael Sugano, Marick Laé, Christophe Battail, Yves Allory, Nicolas Stransky, Sophie Krumeich, Marie‐Helene Donnadieu, Claude Abbou, Simone Benhamou, Thierry Lebret, Xavier Sastre‐Garau, Sebastian Amigorena, François Radvanyi, Clotilde Thery
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): B175.
https://doi.org/10.1158/1535-7163.TARG-09-B175
Published: 10 December 2009
View article titled, Abstract B175: Lactadherin/MFGE8 favors bladder tumor progression by promoting tolerogenic immune responses